Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Recro Pharma (REPH)

Recro Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REPH
DateTimeSourceHeadlineSymbolCompany
06/06/202321:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/06/202321:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
26/05/202321:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
22/05/202322:11Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:REPHRecro Pharma Inc
19/05/202321:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202321:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202321:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202321:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202321:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
19/05/202321:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
18/05/202322:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
10/05/202321:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
03/05/202321:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
06/04/202313:26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REPHRecro Pharma Inc
24/03/202320:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:REPHRecro Pharma Inc
24/03/202320:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
13/03/202311:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
01/03/202322:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
01/03/202321:58Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
01/03/202321:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REPHRecro Pharma Inc
01/03/202321:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
14/02/202319:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
10/02/202314:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/02/202322:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
20/01/202321:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/01/202321:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
05/01/202321:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
03/01/202321:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
20/12/202221:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
16/12/202222:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REPHRecro Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:REPH